{"id":"https://openalex.org/W153219031","doi":null,"title":"Glyburide versus glipizide in the treatment of patients with non-insulin-dependent diabetes mellitus.","display_name":"Glyburide versus glipizide in the treatment of patients with non-insulin-dependent diabetes mellitus.","publication_year":1992,"publication_date":"1992-11-01","ids":{"openalex":"https://openalex.org/W153219031","mag":"153219031","pmid":"https://pubmed.ncbi.nlm.nih.gov/1286487"},"language":"en","primary_location":{"id":"pmid:1286487","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1286487","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical therapeutics","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032014431","display_name":"Charles Kilo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Kilo","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, Missouri","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089798031","display_name":"A Meenan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Meenan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019970806","display_name":"Zachary T. Bloomgarden","orcid":"https://orcid.org/0000-0003-3863-9267","observed_orcids":["https://orcid.org/0000-0003-3863-9267"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Bloomgarden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"14","issue":"6","first_page":"801","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/glipizide","display_name":"glipizide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9810000061988831},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.8489999771118164},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.8059999942779541},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6060000061988831},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.8939999938011169},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8569999933242798},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.902999997138977},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.9380000233650208},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2779555806","wikidata":"https://www.wikidata.org/wiki/Q3108899","display_name":"Glipizide","level":3,"score":0.9927598237991333},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.957782506942749},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7645137310028076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6556179523468018},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5420092344284058},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.47789299488067627},{"id":"https://openalex.org/C27924281","wikidata":"https://www.wikidata.org/wiki/Q17126475","display_name":"Maintenance dose","level":2,"score":0.426663339138031},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4119545519351959}],"mesh":[{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005913","descriptor_name":"Glipizide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005913","descriptor_name":"Glipizide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:1286487","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1286487","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical therapeutics","raw_type":"Clinical Trial"},{"id":"mag:153219031","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1286487","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W93238105","https://openalex.org/W2140297850","https://openalex.org/W69384991","https://openalex.org/W2084918146","https://openalex.org/W2015904026","https://openalex.org/W2169458640","https://openalex.org/W2352745580","https://openalex.org/W2084005354","https://openalex.org/W2045580983","https://openalex.org/W144537546"],"abstract_inverted_index":{"Thirty-four":[0],"adults":[1],"with":[2,129,195,199,204,217,229],"non-insulin-dependent":[3,218],"diabetes":[4,219],"mellitus":[5],"were":[6,29,112,157,193],"randomly":[7],"assigned":[8],"to":[9,137,170],"receive":[10],"either":[11],"oral":[12,15],"glyburide":[13,61,130,192,207],"or":[14,119],"glipizide":[16,70,127,168,209],"in":[17,159],"a":[18],"multicenter":[19],"comparative":[20],"trial.":[21],"Fasting":[22],"blood":[23,117,141,172],"glucose":[24,118,142,173],"and":[25,43,76,94,134,145,148,176,179,208,212],"hemoglobin":[26],"A1c":[27],"(HbA1c)":[28],"assessed":[30],"at":[31,80,95,131,150,181],"the":[32,35,38,44,81,96,99,132,139],"beginning":[33,39,82],"of":[34,40,46,60,69,83,98,126,167,189,201],"titration":[36],"phase,":[37],"maintenance":[41,47,84],"therapy,":[42],"end":[45,97],"therapy.":[48],"Maintenance":[49],"therapy":[50,85,228],"lasted":[51],"approximately":[52],"3":[53],"months.":[54],"The":[55],"initial":[56],"mean":[57],"total":[58,124],"dose":[59],"(5.4":[62],"mg)":[63,72],"was":[64],"significantly":[65,78],"lower":[66,79],"than":[67],"that":[68,165],"(10.6":[71],"(P":[73],"=":[74,107],"0.04)":[75],"remained":[77],"(7.8":[86],"mg":[87,102],"versus":[88,103],"15.3":[89],"mg;":[90,105],"P":[91,106],"<":[92,151,182],"0.01)":[93],"trial":[100],"(10":[101],"16.8":[104],"0.05).":[108],"Although":[109],"significant":[110],"differences":[111],"not":[113],"detected":[114],"for":[115,215],"fasting":[116,140],"HbA1c,":[120],"patients":[121,190,216,223],"received":[122],"higher":[123],"doses":[125,166],"compared":[128,198],"middle":[133],"final":[135],"evaluations":[136],"maintain":[138,171],"between":[143,174],"3.9":[144,175],"10":[146,177],"mmol/L":[147,178],"HbA1c":[149,180],"9%.":[152],"No":[153],"serious":[154],"adverse":[155],"reactions":[156],"observed":[158],"any":[160],"patient.":[161],"These":[162],"results":[163],"indicate":[164],"required":[169],"9%":[183],"increased":[184],"over":[185],"time.":[186],"Seventy-five":[187],"percent":[188],"receiving":[191],"controlled":[194],"once-daily":[196,227],"dosing":[197],"29.4%":[200],"those":[202],"treated":[203],"glipizide.":[205],"Both":[206],"provide":[210],"safe":[211],"effective":[213],"treatment":[214],"mellitus,":[220],"but":[221],"more":[222],"will":[224],"benefit":[225],"from":[226],"glyburide.":[230]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}